| Bioactivity | Laminin B1 (1363-1383) (Compound p4) is a peptide derived from residues 1363-1383 of the Laminin B1 chain that binds to the laminin receptor[1]. |
| CAS | 112761-58-7 |
| Sequence | Lys-Leu-Gln-Ser-Leu-Asp-Leu-Ser-Ala-Ala-Ala-Gln-Met-Thr-Cys-Gly-Thr-Pro-Pro-Gly-Ala |
| Shortening | KLQSLDLSAAAQMTCGTPPGA |
| Formula | C86H146N24O30S2 |
| Molar Mass | 2060.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Iwamoto Y, et al. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR). Br J Cancer. 1996 Mar;73(5):589-95. |
Laminin B1 (1363-1383)
CAS: 112761-58-7 F: C86H146N24O30S2 W: 2060.35
Laminin B1 (1363-1383) (Compound p4) is a peptide derived from residues 1363-1383 of the Laminin B1 chain that binds to
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.